Amarin Corporation plc (Nasdaq: AMRN) to present data for from the MARINE trial, a pivotal Phase 3 study investigating AMR101 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE